Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clémence Montagner

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
La Revue Du Praticien|September 3, 2020
[Autoimmune hemolytic anemias]Benjamin Subran, Clémence Montagner, Olivier Lidove
La Revue Du Praticien|October 15, 2020
[Fabry disease]Benjamin Subran, Clémence Montagner, Jonathan London, et al.
Journal of Bone and Joint Infection|June 4, 2021
Coagulation disorders during treatment with cefazolin and rifampicin: rare but dangerousInes Kouki, Clémence Montagner, Wladimir Mauhin, et al.
Plos One|May 23, 2020
Cornea verticillata and acroparesthesia efficiently discriminate clusters of severity in Fabry diseaseWladimir Mauhin, Olivier Benveniste, Damien Amelin, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
La Revue Du Praticien|September 3, 2020
[Autoimmune hemolytic anemias]Benjamin Subran, Clémence Montagner, Olivier Lidove
La Revue Du Praticien|October 15, 2020
[Fabry disease]Benjamin Subran, Clémence Montagner, Jonathan London, et al.
Journal of Bone and Joint Infection|June 4, 2021
Coagulation disorders during treatment with cefazolin and rifampicin: rare but dangerousInes Kouki, Clémence Montagner, Wladimir Mauhin, et al.
Plos One|May 23, 2020
Cornea verticillata and acroparesthesia efficiently discriminate clusters of severity in Fabry diseaseWladimir Mauhin, Olivier Benveniste, Damien Amelin, et al.
Pageof 1